The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An alternative clinical trial design for early cancer vaccine development to phase 3+3 design.
Emily Gammoh
No relevant relationships to disclose
Osama E. Rahma
No relevant relationships to disclose
Richard Simon
No relevant relationships to disclose
Samir Khleif
No relevant relationships to disclose